You are on the International Aridol Site. US residents select United States.
Since commercialisation in Australia in 2006, the mannitol challenge test (Aridol/Osmohale) has been used in numerous clinical trials, including those run by Pharmaxis, independent investigators, and pharmaceutical companies.
If you would like more information about using Aridol/Osmohale in a clinical trial please click on the appropriate link below;
If you would like information about published clinical trials using mannitol as a bronchial challenge agent please refer to the publications section of this website which can be accessed from the global homepage or by selecting publications.